How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

NCT00913666 ·Status: COMPLETED ·Phase: PHASE4

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen

NCT02076841 ·Status: COMPLETED

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

NCT00168766 ·Status: COMPLETED ·Phase: PHASE4

Study of Evobrutinib in Participants With RMS

NCT04032171 ·Status: TERMINATED ·Phase: PHASE3

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

NCT00179478 ·Status: COMPLETED ·Phase: PHASE4

Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis

NCT00037102 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis

NCT00324506 ·Status: COMPLETED ·Phase: PHASE2

Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.

NCT01405872 ·Status: COMPLETED

A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01975298 ·Status: WITHDRAWN ·Phase: PHASE3

Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis

NCT00223301 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS

NCT00206648 ·Status: COMPLETED ·Phase: PHASE4

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy

NCT00493077 ·Status: COMPLETED ·Phase: PHASE4

Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.

NCT00037115 ·Status: WITHDRAWN ·Phase: PHASE4

Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS

NCT00463710 ·Status: COMPLETED

Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

NCT04032158 ·Status: TERMINATED ·Phase: PHASE3

GER-009-06-AVX Early Therapy in Multiple Sclerosis

NCT00492570 ·Status: COMPLETED

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

NCT00534261 ·Status: COMPLETED ·Phase: PHASE4

Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)

NCT01181115 ·Status: COMPLETED ·Phase: PHASE3

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe

NCT00915577 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of Serum-Free Avonex

NCT00912860 ·Status: COMPLETED ·Phase: PHASE2

AVONEX® Combination Trial - "ACT"

NCT00112034 ·Status: COMPLETED ·Phase: PHASE4

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

NCT00828204 ·Status: COMPLETED ·Phase: PHASE3

Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)

NCT00168714 ·Status: COMPLETED

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

NCT00344253 ·Status: COMPLETED ·Phase: PHASE3

A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a

NCT00771043 ·Status: WITHDRAWN ·Phase: PHASE4